Abstract:
AHRI was initially established to investigate the pathogenesis and human immune responses to
leprosy. But now, it undertakes medical research in a wide range of diseases such as tuberculosis,
malaria, NTDs, HIV and other viruses, antimicrobial resistance, as well as various cancers and
other non-communicable conditions. In 2022, as a result of Proclamation Number 1263/2021
issued for the Definition of Powers and Duties of Executive Organs of the Federal Democratic
Republic of Ethiopia, the mandate of the research institute is expanded by including
responsibilities related with research, development and production of vaccines, diagnostics,
therapeutics, traditional medicine, nutraceutical and other pharmaceuticals. The Institute further
continues to be responsive to the challenges of emerging and reemerging diseases through
medical research and innovation.
